Key result
Elevated GDF-15 tracks myocardial dysfunction in alcohol use disorder and declines during abstinence.
Why the study?
While hepatic injury from chronic alcohol consumption is well characterized, early myocardial involvement in alcohol use disorder and the mechanisms linking hepatic and cardiac injury, including the role of GDF-15, remain poorly understood.
Does alcohol abstinence improve myocardial strain and reduce GDF-15 levels in patients with early-stage alcohol use disorder undergoing inpatient detoxification?
Cohort (n=50)
Does alcohol abstinence improve myocardial strain and reduce GDF-15 levels in patients with early-stage alcohol use disorder undergoing inpatient detoxification?
In early alcohol use disorder, subclinical myocardial dysfunction is linked to gut microbiota-driven systemic inflammation and elevated GDF-15 levels, both of which improve with alcohol abstinence.
Abstinence may aid myocardial recovery in early AUD; extends GDF-15 links but leaves open causal confirmation in trials.
Background/Introduction Chronic alcohol consumption induces persistent low-grade systemic inflammation, contributing to organ dysfunction. While hepatic injury is well characterized, early myocardial involvement in alcohol use disorder (AUD) remains poorly understood. Growth differentiation factor-15 (GDF-15), a stress-induced cytokine, regulates metabolism and inflammation and may link hepatic and cardiac injury. Purpose To investigate mechanisms and biomarkers underlying concurrent liver and myocardial dysfunction in early AUD, with a focus on GDF-15 as a potential hepato-cardiac marker. Methods The study integrated data from a murine model of alcohol-associated liver disease with a human cohort comprising patients with alcohol use disorder (AUD; n = 50) undergoing inpatient detoxification to test the proposed hypothesis. Results In mice fed an ethanol-containing diet, histological liver injury, myocyte thickening, and elevated circulating growth differentiation factor 15 (GDF-15) levels were observed. Patients with early stage of alcohol use disorder (AUD) exhibited impaired myocardial function characterized by elevated E/e′ ratios and reduced global myocardial strain. Circulating GDF-15 levels were increased in AUD and correlated positively with myocardial strain parameters, and systemic inflammatory markers, including LPS-binding protein, TNF, and IL-10. During alcohol abstinence, myocardial strain improved and GDF-15 levels decreased. Notably, higher baseline GDF-15 levels predicted a subsequent improvement in myocardial contractility after sustained abstinence, supporting a potential cardioprotective role of GDF-15. Finally, gut microbiota alterations appeared to be linked to myocardial and inflammatory changes, as the commensal bacterium Parasutterella excrementihominis was inversely associated with GDF-15 levels. Conclusions Alcohol induced myocardial alterations are more likely influenced by microbiota driven inflammation and GDF-15 than toxic effects of ethanol.
No takes yet. Share an insight, caveat, or question.
Grander et al. (2026) conducted a cohort in Early alcohol use disorder (AUD) and alcohol-associated liver disease (n=50). Alcohol use disorder and circulating GDF-15 levels vs. Alcohol abstinence was evaluated on Myocardial function (E/e' ratio and global myocardial strain) and circulating GDF-15 levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: